Imagion Biosystems Ltd. (AU:IBX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Imagion Biosystems Ltd. has reported a substantial increase in revenue by 136.96% to $1.635 million for the half-year ended 30 June 2024, alongside a significant reduction in losses, with a decrease of over 80% to approximately $1.527 million. Despite these improvements, the company did not pay, recommend, or declare any dividends during this period, and the net tangible asset backing per ordinary share decreased slightly.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.